Cargando…
Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients?
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068326/ http://dx.doi.org/10.1186/cc13287 |
| _version_ | 1782322421585412096 |
|---|---|
| author | Pappalardo, F Arnaez, B Celinska-Spodar, M Pieri, M Isella, F Silvetti, S Montisci, A Saleh, O Koster, A |
| author_facet | Pappalardo, F Arnaez, B Celinska-Spodar, M Pieri, M Isella, F Silvetti, S Montisci, A Saleh, O Koster, A |
| author_sort | Pappalardo, F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4068326 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40683262014-07-03 Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? Pappalardo, F Arnaez, B Celinska-Spodar, M Pieri, M Isella, F Silvetti, S Montisci, A Saleh, O Koster, A Crit Care Poster Presentation BioMed Central 2014 2014-03-17 /pmc/articles/PMC4068326/ http://dx.doi.org/10.1186/cc13287 Text en Copyright © 2014 Pappalardo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Pappalardo, F Arnaez, B Celinska-Spodar, M Pieri, M Isella, F Silvetti, S Montisci, A Saleh, O Koster, A Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| title | Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| title_full | Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| title_fullStr | Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| title_full_unstemmed | Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| title_short | Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| title_sort | bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients? |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068326/ http://dx.doi.org/10.1186/cc13287 |
| work_keys_str_mv | AT pappalardof bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT arnaezb bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT celinskaspodarm bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT pierim bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT isellaf bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT silvettis bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT montiscia bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT saleho bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients AT kostera bivalirudinorheparinwhichanticoagulationstrategyforcriticallyillcardiacsurgerypatients |